Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-05-15 7:33 pm Purchase |
2025-03-31 | 13G | Acasti Pharma Inc. ACST |
ADAR1 Capital Management LLC | 1,502,143 9.990% |
472,146 (+45.84%) |
Filing History |
| 2025-05-15 4:46 pm Purchase |
2025-03-31 | 13G | Grace Therapeutics, Inc. GRCE |
Nantahala Capital Management, LLC | 1,391,773 9.990% |
1,391,773 (New Position) |
Filing History |
| 2025-05-08 07:51 am Purchase |
2025-03-31 | 13G | Grace Therapeutics, Inc. GRCE |
Orin Hirschman | 1,322,379 9.900% |
801,296 (+153.78%) |
Filing History |
| 2025-01-29 06:13 am Purchase |
2024-12-31 | 13G | Grace Therapeutics, Inc. GRCE |
Orin Hirschman | 521,083 5.100% |
521,083 (New Position) |
Filing History |
| 2024-11-14 4:40 pm Purchase |
2024-09-30 | 13G | Acasti Pharma Inc. ACST |
ADAR1 Capital Management LLC | 1,029,997 9.990% |
70,426 (+7.34%) |
Filing History |
| 2024-11-14 11:58 am Unchanged |
2024-09-30 | 13G | Acasti Pharma Inc. ACST |
BANK OF AMERICA CORP BAC |
494,698 4.900% |
0 (Unchanged) |
Filing History |
| 2024-07-10 9:10 pm Purchase |
2024-06-28 | 13G | Acasti Pharma Inc. ACST |
ADAR1 Capital Management LLC | 959,571 10.200% |
959,571 (New Position) |
Filing History |
| 2024-04-09 08:46 am Purchase |
2024-03-27 | 13G | Acasti Pharma Inc. ACST |
Orin Hirschman | 567,812 6.000% |
567,812 (New Position) |
Filing History |
| 2024-02-13 7:03 pm Purchase |
2023-12-31 | 13G | Acasti Pharma Inc. ACST |
BANK OF AMERICA CORP BAC |
494,698 5.300% |
494,698 (New Position) |
Filing History |